Question 1

Does Ubs own ALZN stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Ubs holds 2,352 shares of ALZN (Alzamend Neuro), worth $2,822.

Question 2

How many shares of ALZN does Ubs own?

Accepted Answer

As of its Q2 2026 13F, Ubs holds 2,352 shares of ALZN (Alzamend Neuro).

Question 3

What is Ubs' ALZN position worth?

Accepted Answer

As of its Q2 2026 13F, Ubs' ALZN position is worth $2,822.

Question 4

Is Ubs buying or selling ALZN?

Accepted Answer

In Q2 2026, Ubs reduced its ALZN position by 2,152 shares (-47.8%).

Question 5

When did Ubs first buy ALZN?

Accepted Answer

Ubs first reported ALZN in its Q2 2025 13F and has listed it in 5 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	2,352	-47.8%	$2,822	0.0%	$1.20	0
2026-Q1	Decreased	4,504	-81.7%	$4,774	0.0%	$1.88	0
2025-Q4	Increased	24,567	+1084.0%	$44,712	0.0%	$1.92	22
2025-Q3	Increased	2,075	+130.0%	$4,939	0.0%	$2.36	16
2025-Q2	New	902	-	$2,625	0.0%	$2.90	19

ALZN5 quarters

ALZN
5 quarters